Chemical abortion now accounts for nearly two-thirds of all abortions in the United States, 63%, according to the Guttmacher Institute. That’s a dramatic shift in how abortions are performed, and it’s happening at the same moment that serious questions are emerging about whether women are being adequately protected from the risks involved. Here’s what the data actually shows. The FDA Label Doesn’t Tell the Whole Story The FDA’s current label for mifepristone, the first drug in the standard two-drug chemical abortion regimen, states that fewer than 0.5% of women experience serious adverse reactions. Abortion advocates have leaned heavily on this...